Roche late stage trial for immunotherapy lung cancer treatment fails | Financial Post

Retrieved on: 2022-03-30 06:07:13

Tags for this article:

Click the tags to see associated articles and topics

Roche late stage trial for immunotherapy lung cancer treatment fails | Financial Post. View article details on hiswai:

Excerpt

ZURICH — Roche said on Wednesday a late stage trial for its tiragolumab drug to treat small cell lung cancer has failed to reach its targets, ...

Article found on: financialpost.com